HRT Financial’s Coya Therapeutics COYA Stock Holding History

HRT Financial’s Portfolio COYA Stock Details COYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,517	Closed	-$53K	–	4369
2026 Q1	$53K	Buy	+13,517	New	+$63.2K	﹤0.01%	3448

Other funds holding COYA

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

HRT Financial's COYA Position: Q2 2026 in Review

HRT Financial sold out of Coya Therapeutics (COYA) in Q2 2026, closing a stake of 13,517 shares — an estimated $53K sold.

HRT Financial first reported a position in COYA in Q1 2026 and held it in 1 quarter. The position peaked at $53K in Q1 2026. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

HRT Financial reported no remaining Coya Therapeutics position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 13,517 Coya Therapeutics shares in Q2 2026, an estimated $53K.
HRT Financial first reported a position in Coya Therapeutics in Q1 2026 and held it in 1 quarter.
HRT Financial's Coya Therapeutics position peaked at $53K in Q1 2026.
54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.